Ashland
Supplies specialty ingredients and additives through its business segments.
Something off on this page? Send us feedback.
Profile
Organizes additives and specialty ingredients across Life Sciences, Personal Care, Specialty Additives, and Intermediates. The portfolio serves consumer and industrial markets after a long transition away from refining.
Supplies additives and specialty ingredients to consumer and industrial markets. Life Sciences, Personal Care, Specialty Additives, and Intermediates are the reported segments, serving architectural coatings, construction, energy, food and beverage, personal care, and pharmaceuticals. The current portfolio reflects a long exit from refining, marketing, distribution, water technologies, and Valvoline.
Customers are spread across more than 100 countries, making international markets integral to the operating model. The company has legacy environmental assessment and remediation obligations at former and current operating facilities and service-station properties. Work at identified Superfund or analogous state-law sites remains subject to EPA or state-agency oversight and to cost estimates.
Company facts
Key statistics
Year to date +24.3% · Average volume (30d) 716.3K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Morgan Stanley | Reiterate | Equal Weight | $58 | $78 | |
| Jul 31, 2026 | Deutsche Bank | Reiterate | Buy | $60 | $85 | |
| Jul 30, 2026 | UBS | Reiterate | Buy | $72 | $83 | |
| Jul 29, 2026 | BMO Capital | Reiterate | Outperform | $71 | $75 | |
| Jul 29, 2026 | Mizuho Securities | Target | $70 | $77 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026Q3 FY26 | $0.99 | $1.02 | +3.6% | $486.0M | $497.0M | +2.3% | +7.10% |
| Apr 28, 2026Q2 FY26 | $0.97 | $0.91 | −6.2% | $485.6M | $482.0M | −0.7% | −13.77% |
| Feb 2, 2026Q1 FY26 | $0.23 | $0.26 | +13.0% | $400.9M | $386.0M | −3.7% | −0.78% |
| Nov 4, 2025Q4 FY25 | $1.17 | $1.08 | −7.7% | $397.1M | $478.0M | +20.4% | +6.06% |
Financial highlights
| 12 quarters | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $479.0M | $463.0M | $478.0M | $386.0M | $482.0M | $497.0M | |
| Gross profit | $147.0M | $70.0M | $159.0M | $80.0M | $147.0M | $155.0M | |
| Operating income | $51.0M | −$16.0M | $61.0M | −$6.0M | $39.0M | $41.0M | |
| Net income | $31.0M | −$742.0M | $32.0M | −$12.0M | $16.0M | $16.0M | |
| Diluted EPS | $0.65 | −$16.13 | $0.70 | −$0.26 | $0.34 | $0.35 | |
| Gross margin | 30.7% | 15.1% | 33.3% | 20.7% | 30.5% | 31.2% | |
| Operating margin | 10.6% | -3.5% | 12.8% | -1.6% | 8.1% | 8.2% |
Fiscal years (4-quarter sums)FY21 $1.85B · FY22 $2.39B · FY23 $2.19B · FY24 $2.11B · FY25 $1.83B
Revenue by product · Q3 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $440.0M · Total debt $1.48B · Total assets $4.58B · Shareholders' equity $1.87B
Dividends
Raised for 16 straight years — most recently to $0.42 from $0.415 in Jun 2026. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jun 1, 2026 | Jun 1 | Jun 15 | $0.42 | raised from $0.415 |
| Feb 27, 2026 | Mar 1 | Mar 15 | $0.415 | |
| Dec 1, 2025 | Dec 1 | Dec 15 | $0.415 | |
| Aug 29, 2025 | Sep 1 | Sep 15 | $0.415 | |
| May 30, 2025 | Jun 1 | Jun 15 | $0.415 | raised from $0.405 |
| Feb 28, 2025 | Mar 1 | Mar 15 | $0.405 | |
| Nov 29, 2024 | Dec 1 | Dec 15 | $0.405 | |
| Aug 30, 2024 | Sep 1 | Sep 15 | $0.405 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 45.79M · Float 41.05M · 89.6% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.71M | 12.47% | 13F | Aug 7, 2026 |
| Standard Investments LLC | 4.53M | 9.88% | 13F | Aug 14, 2026 |
| Standard Latitude Fund LP | 4.10M | 8.94% | 13D | May 18, 2026 |
| Franklin Resources, Inc. | 3.62M | 7.90% | 13G | Jul 28, 2026 |
| Cooperman Leon G | 2.92M | 6.40% | 13G | Aug 5, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
View detailsPeers
- Dow
Cellulose ethers for construction and coatings formulations
- Innospec
Personal-care and construction formulation additives
- Stepan
Surfactants, emollients, and emulsifiers for personal care
